During the past decade, Ausl 11 Di Empoli (Fi) - Empoli (Fi) Oncologia Medica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ausl 11 Di Empoli (Fi) - Empoli (Fi) Oncologia Medica" are "Colorectal Cancer" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Ausl 11 Di Empoli (Fi) - Empoli (Fi) Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Ausl 11 Di Empoli (Fi) - Empoli (Fi) Oncologia Medica" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "FOLFIRI" (1 trials), "FOLFOXIRI" (1 trials), "bevacizumab" (1 trials), "fluorouracil" (1 trials) and "irinotecan hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ausl 11 Di Empoli (Fi) - Empoli (Fi) Oncologia Medica" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ausl 11 Di Empoli (Fi) - Empoli (Fi) Oncologia Medica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ausl 11 Di Empoli (Fi) - Empoli (Fi) Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ausl 11 Di Empoli (Fi) - Empoli (Fi) Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".